Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,558,775
+$673,394 QoQ
Shares Held
25,825
+7.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#1,408
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 9%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gryphon Financial Partners LLC holds $43,846,091 across 10 Drug Manufacturers - General names. JNJ ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
91,741 | $23,085,705 | |
| 2 | LLY |
ELI LILLY & Co
|
6,418 | $7,697,942 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
25,825 | $6,558,775 | |
| 4 | AMGN |
Amgen Inc
|
5,868 | $2,124,920 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,044 | $2,061,654 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,540 | $826,263 | |
| 7 | GSK |
GSK plc
|
15,580 | $816,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,157 | $239,526 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,558,775 | 25,825 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $5,885,381 | 24,077 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,586,012 | 22,160 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $3,833,002 | 20,672 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,034,225 | 19,864 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,747,968 | 16,570 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,476,182 | 17,122 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $2,434,302 | 15,021 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,126,189 | 14,547 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,137,621 | 13,513 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,232,760 | 14,245 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,333,998 | 8,565 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,396,492 | 8,437 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,398,565 | 9,023 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,728,342 | 9,784 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,577,076 | 9,654 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,511,141 | 8,513 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,386,469 | 7,823 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $1,549,037 | 9,055 | Shares | Other | 2022-02-01 | |
| 2021-09-30 | $1,125,492 | 6,969 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $990,415 | 6,012 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $884,694 | 5,383 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $1,162,093 | 7,384 | Shares | Other | 2021-02-10 | |
| 2020-09-30 | $804,248 | 5,402 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $754,057 | 5,362 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $677,810 | 5,169 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||